| Monday, May 13th 12:45 - 15:45 Room Oak Bay 2 Working group session I | Tuesday, May 14th 10:00 - 15:00 Room Oak Bay 2 Working group session II | Wednesday, May 15th 15:15 - 16:45 Theatre Symposium IX | ||||||||
| 12:45 | Introduction Core lecture Description of the project Methodological aspects I | Chair: J. Mytilineos, I. Hutchinson | 10:00 | Lectures about Cytokine and Cytokine Receptor Molecules, their Function, their Genetic Organisation, Polymorphisms described so far, and their possible Functional Relevance | Chair: J. Mytilineos, A.C. Goldberg | 15:15 | I. Hutchinson Cytokine Gene Polymorphisms - State of the Art | Chair: J. Mytilineos, F. Christiansen | ||
| 12:50 | 10:05 | 15:20 | ||||||||
| 12:55 | 10:10 | 15:25 | ||||||||
| 13:00 | 10:15 | 15:30 | ||||||||
| 13:05 | 10:20 | 15:35 | J. Mytilineos The CGP-Component Study concept, Statistics, Participation | |||||||
| 13:10 | 10:25 | 15:40 | ||||||||
| 13:15 | 10:30 | 15:45 | ||||||||
| 13:20 | 10:35 | 15:50 | J. Mytilineos Phase I + II QC results | |||||||
| 13:25 | 10:40 | 15:55 | ||||||||
| 13:30 | 10:45 | 16:00 | NN Summary of the Phase II studies | |||||||
| 13:35 | 10:50 | 16:05 | ||||||||
| 13:40 | 10:55 | 16:10 | ||||||||
| 13:45 | 11:00 | Phase II Results of the various Cytokine Gene Polymorphism Component Participants | 16:15 | |||||||
| 13:50 | 11:05 | 16:20 | ||||||||
| 13:55 | 11:10 | 16:25 | ||||||||
| 14:00 | 11:15 | 16:30 | J. Mytilineos Future Plans and Prospectives | |||||||
| 14:05 | 11:20 | 16:35 | ||||||||
| 14:10 | 11:25 | 16:40 | ||||||||
| 14:15 | Coffee Break | 11:30 | 16:45 | |||||||
| 14:20 | 11:35 | |||||||||
| 14:25 | 11:40 | |||||||||
| 14:30 | Methodological aspects II QC-results phases I and II | Chair: A. Castley, M.-T. Lin | 11:45 | |||||||
| 14:35 | 11:50 | Short Break | ||||||||
| 14:40 | 11:55 | |||||||||
| 14:45 | 12:00 | Phase II Results of the various Cytokine Gene Polymorphism Component Participants | Chair: T. Juji, V. Pravica | |||||||
| 14:50 | 12:05 | |||||||||
| 14:55 | 12:10 | |||||||||
| 15:00 | 12:15 | |||||||||
| 15:05 | 12:20 | |||||||||
| 15:10 | 12:25 | |||||||||
| 15:15 | 12:30 | |||||||||
| 15:20 | 12:35 | |||||||||
| 15:25 | 12:40 | |||||||||
| 15:30 | 12:45 | |||||||||
| 15:35 | General Discussion | 12:50 | ||||||||
| 15:40 | 12:55 | |||||||||
| 15:45 | 13:00 | |||||||||
| 13:05 | ||||||||||
| 13:10 | ||||||||||
| 13:15 | ||||||||||
| 13:20 | ||||||||||
| 13:25 | ||||||||||
| 13:30 | Coffee Break | |||||||||
| 13:35 | ||||||||||
| 13:40 | ||||||||||
| 13:45 | Phase II Results of the various Cytokine Gene Polymorphism Component Participants | Chair: D. Turner, F. Christiansen | ||||||||
| 13:50 | ||||||||||
| 13:55 | ||||||||||
| 14:00 | ||||||||||
| 14:05 | ||||||||||
| 14:10 | ||||||||||
| 14:15 | ||||||||||
| 14:20 | ||||||||||
| 14:25 | ||||||||||
| 14:30 | ||||||||||
| 14:35 | General Discussion Future Projects HSCT-Plans | |||||||||
| 14:40 | ||||||||||
| 14:45 | ||||||||||
| 14:50 | ||||||||||
| 14:55 | ||||||||||
| Monday, May 13th 12:45 - 15:45 Room Oak Bay 2 Working group session I | Tuesday, May 14th 10:00 - 15:00 Room Oak Bay 2 Working group session II | Wednesday, May 15th 15:15 - 16:45 Theatre Symposium IX | ||||||||
| 12:45 | I. Hutchinson Cytokine Gene Polymorphisms | Chair: J. Mytilineos, I. Hutchinson | 10:00 | B. Hutyrova, A. Slavcev, M. Petrek IL1 gene cluster polymorphisms | Chair: J. Mytilineos, A.C. Goldberg | 15:15 | I. Hutchinson Cytokine Gene Polymorphisms - State of the Art | Chair: J. Mytilineos, F. Christiansen | ||
| 12:50 | 10:05 | 15:20 | ||||||||
| 12:55 | 10:10 | 15:25 | ||||||||
| 13:00 | 10:15 | D. Turner IL2, TGFß | 15:30 | |||||||
| 13:05 | 10:20 | 15:35 | J. Mytilineos The CGP-Component Study concept, Statistics, Participation | |||||||
| 13:10 | 10:25 | M.E. Fasano, IL4 | 15:40 | |||||||
| 13:15 | J. Mytilineos The CGP Component. Study Set Up, Participation, Statistics | 10:30 | G. Saruhan, IL4R | 15:45 | ||||||
| 13:20 | 10:35 | A. Castley IL6, IL10, IL12, TNFa | 15:50 | J. Mytilineos Phase I + II QC results | ||||||
| 13:25 | 10:40 | 15:55 | ||||||||
| 13:30 | E. Michelson The Phase I and II panels | 10:45 | 16:00 | NN Summary of the Phase II studies | ||||||
| 13:35 | 10:50 | 16:05 | ||||||||
| 13:40 | J. Mytilineos The IHWC PCR-SSP Kit | 10:55 | V. Pravica, g-IFN | 16:10 | ||||||
| 13:45 | 11:00 | D. Adorno? L'Aquila, ITA | 16:15 | |||||||
| 13:50 | W. Helmberg Cytokine SCORE | 11:05 | 16:20 | |||||||
| 13:55 | 11:10 | A. Castley, F. Christiansen Perth, AUS | 16:25 | |||||||
| 14:00 | D. Middleton Cytokine Genotyping by the PCR-SSOP method. The Belfast experience | 11:15 | 16:30 | J. Mytilineos Future Plans and Prospectives | ||||||
| 14:05 | 11:20 | J. Mytilineos, G. Opelz Heidelberg, GER | 16:35 | |||||||
| 14:10 | 11:25 | 16:40 | ||||||||
| 14:15 | Coffee Break | 11:30 | M.E. Fasano, S. Curtoni Torino, ITA | 16:45 | ||||||
| 14:20 | 11:35 | |||||||||
| 14:25 | 11:40 | Y. Ishikawa, T. Juji Tokio, JAP | ||||||||
| 14:30 | D. Turner Cytokine SNaPshot(ting) | Chair: A. Castley, M.-T. Lin | 11:45 | |||||||
| 14:35 | 11:50 | Short Break | ||||||||
| 14:40 | V. Pravica Genotype in Manchester | 11:55 | ||||||||
| 14:45 | 12:00 | L. Louie Oakland, USA | Chair: T. Juji, V. Pravica | |||||||
| 14:50 | M.-T. Lin Cytokine Typing by the PCR-RFLP method | 12:05 | ||||||||
| 14:55 | 12:10 | N. Mehra New Delhi, IND | ||||||||
| 15:00 | G. Laux Statistical Analysis of the QC Data (Phase I+II) | 12:15 | ||||||||
| 15:05 | 12:20 | A. Albukerque, J. R. Moraes Rio de Janeiro, BRA | ||||||||
| 15:10 | J. Mytilineos The Phase I + II QC-results | 12:25 | ||||||||
| 15:15 | 12:30 | C. Gorodetzky Mexico City, MEX | ||||||||
| 15:20 | 12:35 | |||||||||
| 15:25 | A. Castley Alternative Detection Methods | 12:40 | P.Lazidou, L.Papakyriazi Z. Polymenidis Thessaloniki, GR | |||||||
| 15:30 | 12:45 | |||||||||
| 15:35 | General Discussion | 12:50 | R. Rani New Delhi, IND | |||||||
| 15:40 | 12:55 | |||||||||
| 15:45 | 13:00 | G. Saruhan-Direskeneli Istanbul, TUR | ||||||||
| 13:05 | ||||||||||
| 13:10 | A. Slavcev, O. Cinek Prague, CZE | |||||||||
| 13:15 | ||||||||||
| 13:20 | M.-T. Lin, J. Hansen Seattle, USA | |||||||||
| 13:25 | ||||||||||
| 13:30 | Coffee Break | |||||||||
| 13:35 | ||||||||||
| 13:40 | ||||||||||
| 13:45 | Z. Varghese, D. Turner London, UK | Chair: F. Christiansen, D. Turner | ||||||||
| 13:50 | ||||||||||
| 13:55 | K. Nelson Seattle, USA | |||||||||
| 14:00 | ||||||||||
| 14:05 | A. Amirzargar, P. Nikbin Tehran, IRA | |||||||||
| 14:10 | ||||||||||
| 14:15 | A.C. Goldberg, J. Kalil Sao Paulo, BRA | |||||||||
| 14:20 | ||||||||||
| 14:25 | Y. Takato, A. Kimura Yokohama/Kanagawa, JAP | |||||||||
| 14:30 | ||||||||||
| 14:35 | General Discussion Future Projects HSCT-Plans | |||||||||
| 14:40 | ||||||||||
| 14:45 | ||||||||||
| 14:50 | ||||||||||
| 14:55 | ||||||||||